Medical Oncology

, Volume 28, Issue 4, pp 1589–1595 | Cite as

Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement

  • Barbara Pienkowska-GrelaEmail author
  • Grzegorz Rymkiewicz
  • Beata Grygalewicz
  • Renata Woroniecka
  • Paulina Krawczyk
  • Katarzyna Czyz-Domanska
  • Jan Walewski
Original Paper


Burkitt lymphoma (BL) is an aggressive non-Hodgkin lymphoma characterized by specific morphological and immunophenotypic features. The basic genetic feature of BL is the rearrangement of MYC gene, visible as t(8;14)(q24;q32) translocation or its variant. However, some lymphomas with characteristic BL morphology are nowadays diagnosed as B-cell lymphoma unclassifiable with features intermediate between DLBCL and BL (Inter-DLBCL/BL) for biological or clinical reasons. We present four lymphomas without the MYC rearrangement presented typical Burkitt morphology, FCM immunophenotype with some deviations when compared to a typical BL. The cases were finally diagnosed as Inter-DLBCL/BL. All of them presented a recurrent abnormality within the chromosome 11: dup(11)(q23q13). We suppose that the dup(11)(q23q13), in absence of the MYC gene rearrangement, is connected with borderline lymphomas with a morphology similar or identical to that of the Burkitt lymphoma. Identifying such an aberration may be helpful in the diagnostics of Inter-DLBCL/BL eventually forming a distinct subgroup of lymphomas.


Non-Hodgkin’s lymphoma Burkitt morphology Chromosome aberrations FISH 


  1. 1.
    Dave SS, et al. Lymphoma/leukemia molecular profiling project. Molecular diagnosis of Burkitt’s lymphoma. N Engl J Med. 2006;354:2431–42.PubMedCrossRefGoogle Scholar
  2. 2.
    Kluin PM. B-cell lymphoma, unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 265–6.Google Scholar
  3. 3.
    Leoncini L. Burkitt lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 262–4.Google Scholar
  4. 4.
    Sevilla DW, et al. Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation. Am J Clin Pathol. 2007;128(6):981–91.PubMedCrossRefGoogle Scholar
  5. 5.
    Harris NL, Horning SJ. Burkitt’s lymphoma—the message from microarrays. N Engl J Med. 2006;354:2495–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Patte C, et al. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescent: it is possible to reduce treatment for the early responding patients. Blood. 2007;109:2773–80.PubMedGoogle Scholar
  7. 7.
    Margath IT, et al. An effective therapy for both undifferentiated (including Burkitt’s) lymphomas and lymphoblastic lymphomas in children and young adults. Blood. 1984;63:1102–11.Google Scholar
  8. 8.
    Diebold J, Jaffe ES, Raphael M, Warnke RA. Burkitt lymphoma. In: Jaffe E, Harris NL, Stein H, Vardiman JW, editors. Pathology and genetics: tumours of haematopoietic and lymphoid tumours. Lyon: AIARC Press; 2001. p. 181–4.Google Scholar
  9. 9.
    Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004;104:3009–20.PubMedCrossRefGoogle Scholar
  10. 10.
    Hecht JL, Aster JC. Molecular biology of Burkitt’s lymphoma. J Clin Oncol. 2000;18:3707–21.PubMedGoogle Scholar
  11. 11.
    Chan NP, Ma ES, Wan TS, Chan LC. The spectrum of acute lymphoblastic leukemia with mature B-cell phenotype. Leuk Res. 2003;27:231–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Perkins AS, Friedberg JW. Burkitt lymphoma in adults. Hematology Am Soc Hematol Educ Program.
  13. 13.
    Hummel M, Bentink S, Berger H. A biological definition of Burkitt’s lymphoma from transcriptional and genomic profiling. N Engl J Med. 2006;354:2419–30.PubMedCrossRefGoogle Scholar
  14. 14.
    Shaffer LG, Tommerup N, editors. ISCN: an international system for human cytogenetic nomenclature. Basel: S. Karger; 2005.Google Scholar
  15. 15.
    Mitelman Database of Chromosome Aberrations in Cancer, The Cancer Genome Anatomy Project Accessed 14 July 2009.
  16. 16.
    Koduru PRK, Offit K, Jhanwar SC. Molecular analysis of structural chromosome changes affecting chromosome band 11q23. Dis Markers. 1989;7:145–52.PubMedGoogle Scholar
  17. 17.
    Leucci E, et al. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol. 2008;216:440–50.PubMedCrossRefGoogle Scholar
  18. 18.
    Jerkeman M, et al. Prognostic implication of cytogenetic aberrations in diffuse large B-cell lymphomas. Eur J Haematol. 1999;62:184–90.PubMedCrossRefGoogle Scholar
  19. 19.
    Espinet B, Florensa L, Salido M, Solé F. MLL intrachromosomal amplification in a pre-B acute lymphoblastic leukemia. Haematologica. 2003;88(2):EIM03.PubMedGoogle Scholar
  20. 20.
    Deisch J, et al. Segmental tandem triplication of the MLL gene in an intravascular large B-cell lymphoma with multisystem involvement: a comprehensive morphologic, immunophenotypic, cytogenetic, and molecular cytogenetic antemortem study. Arch Pathol Lab Med. 2009;133(9):1477–82.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Barbara Pienkowska-Grela
    • 1
    Email author
  • Grzegorz Rymkiewicz
    • 2
  • Beata Grygalewicz
    • 1
  • Renata Woroniecka
    • 1
  • Paulina Krawczyk
    • 1
  • Katarzyna Czyz-Domanska
    • 3
  • Jan Walewski
    • 3
  1. 1.Cytogenetic LaboratoryMSCM Cancer Centre and InstituteWarsawPoland
  2. 2.Flow Cytometry LaboratoryMSCM Cancer Centre and InstituteWarsawPoland
  3. 3.Department of Lymphoprolipherative DiseaseMSCM Cancer Centre and InstituteWarsawPoland

Personalised recommendations